2022 Hyundai Elantra
2.0 L • 4 • 276 hp • FWD • AT
KMHLW4AK3NU008351
Sales history: 37
• $7,200Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
37 records
Drive
2.0 L • 4 • 276 hp • FWD • AT
Odometer
20,067 mi ≈ 32,295 km
Primary damage
Front end
Docs
MO • Salvage Title
Extra
Auction
VIN
KMHLW4AK3NU008351
Lot number
47886904
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
St. Louis, MO
Description
Fuel type
Gasoline
Body color
White
Body type
Sedan
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2022 Hyundai Elantra • 2.0 L • 4 cyl • 276 hp • FWD • Automatic • Copart Lot: 47886904 • VIN: KMHLW4AK3NU008351
Find out more about this 2022 Hyundai Elantra, available at the Copart salvage car auction as lot #47886904 in St. Louis, MO. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 20,067 mi. This White Hyundai Elantra Sedan is equipped with Gasoline 2.0 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KMHLW4AK3NU008351 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
